Osaic Holdings
XENE icon

Osaic Holdings’s Xenon Pharmaceuticals XENE Stock Holding History

Osaic Holdings’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
332
-57
-15% -$3.17K ﹤0.01% 6161
2026
Q1 		$22.6K Buy
389
+70
+22% +$3.23K ﹤0.01% 5772
2025
Q4 		$14.3K Sell
319
-1,055
-77% -$44.3K ﹤0.01% 6095
2025
Q3 		$55K Buy
1,374
+149
+12% +$5.25K ﹤0.01% 5251
2025
Q2 		$40.2K Buy
1,225
+1,034
+541% +$33.7K ﹤0.01% 5210
2025
Q1 		$6.41K Sell
191
-272
-59% -$10.3K ﹤0.01% 6042
2024
Q4 		$18.1K Buy
463
+4
+0.9% +$165 ﹤0.01% 5415
2024
Q3 		$18.1K Sell
459
-78
-15% -$3.15K ﹤0.01% 5448
2024
Q2 		$20.9K Sell
537
-293
-35% -$11.7K ﹤0.01% 5316
2024
Q1 		$35.7K Sell
830
-1,835
-69% -$84.4K ﹤0.01% 4972
2023
Q4 		$123K Sell
2,665
-1,222
-31% -$43.2K ﹤0.01% 4280
2023
Q3 		$133K Buy
3,887
+1,196
+44% +$44.7K ﹤0.01% 4293
2023
Q2 		$104K Buy
2,691
+2,009
+295% +$79.9K ﹤0.01% 4409
2023
Q1 		$24.4K Buy
682
+6
+0.9% +$222 ﹤0.01% 5456
2022
Q4 		$27K Buy
676
+85
+14% +$3.1K ﹤0.01% 5372
2022
Q3 		$22K Buy
591
+328
+125% +$11.8K ﹤0.01% 5526
2022
Q2 		$8K Buy
263
+163
+163% +$4.93K ﹤0.01% 6257
2022
Q1 		$3K Hold
100
– – ﹤0.01% 6785
2021
Q4 		$3K Sell
100
-275
-73% -$8.22K ﹤0.01% 6922
2021
Q3 		$6K Hold
375
– – ﹤0.01% 6477
2021
Q2 		$7K Sell
375
-375
-50% -$6.91K ﹤0.01% 6266
2021
Q1 		$13K Hold
750
– – ﹤0.01% 5749
2020
Q4 		$12K Hold
750
– – ﹤0.01% 5449
2020
Q3 		$8K Hold
750
– – ﹤0.01% 5404
2020
Q2 		$9K Hold
750
– – ﹤0.01% 5243
2020
Q1 		$9K Buy
+750
New +$10.7K ﹤0.01% 5084

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Osaic Holdings's XENE Position: Q2 2026 in Review

Osaic Holdings reduced its Xenon Pharmaceuticals (XENE) stake by 15% in Q2 2026, selling an estimated $3.17K and leaving 332 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #6161.

Osaic Holdings first reported a position in XENE in Q1 2020 and has held it in 26 quarters since. The position peaked at $133K in Q3 2023. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Osaic Holdings held 332 shares of Xenon Pharmaceuticals worth $20K as of Q2 2026.
  • Osaic Holdings sold 57 Xenon Pharmaceuticals shares in Q2 2026, an estimated $3.17K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6161 holding.
  • Osaic Holdings first reported a position in Xenon Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Xenon Pharmaceuticals position peaked at $133K in Q3 2023.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.